These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35793873)

  • 21. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
    Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
    Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
    Pak MG; Shin DH; Lee CH; Lee MK
    World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High SOX2 levels predict better outcome in non-small cell lung carcinomas.
    Velcheti V; Schalper K; Yao X; Cheng H; Kocoglu M; Dhodapkar K; Deng Y; Gettinger S; Rimm DL
    PLoS One; 2013; 8(4):e61427. PubMed ID: 23620753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.
    Qu Y; Emoto K; Eguchi T; Aly RG; Zheng H; Chaft JE; Tan KS; Jones DR; Kris MG; Adusumilli PS; Travis WD
    J Thorac Oncol; 2019 Mar; 14(3):482-493. PubMed ID: 30503889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
    Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.
    Rocha P; Rodrigo M; Moliner L; Menendez S; Masfarré L; Navarro N; Del Rey-Vergara R; Galindo-Campos M; Taus Á; Giner M; Sanchez I; Rodríguez-Fuster A; Aguiló R; Chalela R; Sánchez-Font A; Belda J; Curull V; Pijuan L; Casadevall D; Clavé S; Bellosillo B; Perera-Bel J; Comerma L; Arriola E
    Lung Cancer; 2023 Jul; 181():107257. PubMed ID: 37263182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
    Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
    Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
    Ma J; Liu L; Che G; Yu N; Dai F; You Z
    BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Shen E; Xiu J; Bentley R; López GY; Walsh KM
    Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
    Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
    Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
    Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
    Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
    Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non-Small Cell Lung Cancer.
    Porciuncula A; Morgado M; Gupta R; Syrigos K; Meehan R; Zacharek SJ; Frederick JP; Schalper KA
    Clin Cancer Res; 2021 Nov; 27(22):6174-6183. PubMed ID: 34518312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
    PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
    Piper AJ; Clark JL; Mercado-Matos J; Matthew-Onabanjo AN; Hsieh CC; Akalin A; Shaw LM
    PLoS One; 2019; 14(8):e0220567. PubMed ID: 31393907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].
    Cheng Y; Li H; Zhao D; Han Q; Liu Y; Liu X; Ma L; Liu J
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):592-6. PubMed ID: 25430025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.